Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Oncology > Companies > Flashcards

Companies Flashcards

1
Q

Adaptive biotechnologies

A

clonoSEQ® is available as an FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies to detect measurable residual disease (MRD) in bone marrow from patients with multiple myeloma or B-cell acute lymphoblastic leukemia (B-ALL) and blood or bone marrow from patients with chronic lymphocytic leukemia (CLL). clonoSEQ is also available for use in other lymphoid cancers as a CLIA-validated laboratory developed test (LDT) service. For important information about the FDA-cleared uses of clonoSEQ including test limitations, please visit clonoSEQ.com/technical-summary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Athenex

A

MBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Amgen

A

KRAS G12C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Annexus Health

A

Annexus Health is a privately-held healthcare technology company focused on developing solutions that reduce administrative burdens across the patient journey to improve access, speed, and adherence to critical care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AON

A

American Oncology Network, LLC (AON) is an alliance of physicians and veteran healthcare leaders dedicated to ensuring the long-term success and viability of oncology diagnosis and treatment in community-based settings. It is the fastest growing network of community oncology practices delivering local access to exceptional cancer care. Launched in 2018 by the physicians and administrators from the nations’ largest independent community oncology practice, AON’s network has expanded in two years to include more than 150 providers in 16 states.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Astra Zeneca

A 
IMFINZI® (durvalumab) 
TAGRISSO® (osimertinib) 
CALQUENCE® (acalabrutinib) 
LYNPARZA® (olaparib) 
ENHERTU® (fam-trastuzumab deruxtecan-nxki)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Astellas

A

XTANDI®(enzalutamide) capsules, XOSPATA® (gilteritinib) tablets, PADCEV® (enfortumab vedotin-ejfv)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AVEO

A

FOTIVDA (tivozanib)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BeiGene

A

Brukinsa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardinal Health

A

Cardinal Health Specialty Solutions and VitalSource™ GPO empower community oncology practices to navigate the future of oncology care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Eisai

A

LENVIMA (Lenvatinib)

HALAVEN (eribulin mesylate) injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EMD Serono

A

BAVENCIO (avelumab)
Immuno-oncology is a top priority for EMD Serono a business of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. The global strategic alliance between Merck KGaA, Darmstadt, Germany, and Pfizer Inc., New York, US, enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab, an anti-PD-L1 antibody initially discovered and developed by Merck KGaA, Darmstadt, Germany. The immuno-oncology alliance will jointly develop and commercialize avelumab and advance Pfizer’s PD-1 antibody. The alliance is focused on developing high-priority international clinical programs to investigate avelumab as a monotherapy, as well as in combination regimens, and is striving to find new ways to treat cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

EUSA

A

SYLVANT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Flatiron

A

Flatiron Health is a healthtech company that marries clinical and data science to improve outcomes for cancer patients today and tomorrow. We translate patient experiences into real-world evidence to advance research and inform policy. Flatiron HC isn’t just the leading cancer-specific EHR. It’s the platform for a better patient experience, a healthier practice and smarter research. We help oncologists provide better care for their patients. Together, we can outsmart cancer. Flatiron Health is an independent affiliate of the Roche Group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

G! Therapeutics

A

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GSK

A

ZEJULA

17
Q

Heron therapeutics

A

SUSTOL® (granisetron) extended-release injection

CINVANTI® (aprepitant) injectable emulsion

18
Q

Incyte

A

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visitIncyte.comand follow @Incyte. For more information on Jakafi® (ruxolitinib), visithcp.jakafi.com. For more information on MONJUVI® (tafasitamab-cxix), visitmonjuvihcp.com. For more information on Pemazyre® (pemigatinib), visithcp.pemazyre.com

19
Q

ION

A

Community-based oncologists rely on ION Solutions for creative GPO contracting, integrated dispensing solutions, and the expertise practices need to improve clinical and operational management. Pharmaceutical manufacturers rely on us as a trusted preferred partner for achieving product exposure and driving growth with existing products. Managed care companies depend on us to develop innovative programs to reduce overall costs and variability of care among our practices.

20
Q

Ipsen

A

ONIVYDE

Somatuline Depot

21
Q

Janssen Oncology

A

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
IMBRUVICA® (ibrutinib)
ERLEADA® (apalutamide)

22
Q

McKesson

A

McKesson is a global leader in healthcare supply chain management, retail pharmacy, healthcare technology, community oncology and specialty care.

23
Q

MorphoSys

A

MONJUVI

24
Q

Myriad

A

Myriad Genetics, Inc. is a leading personalized medicine company dedicated to being a trusted advisor and transforming patient lives worldwide with molecular diagnostics. Myriad discovers and commercializes diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs.

25
Q

Natera

A

Signatera is a personalized ctDNA test for molecular residual disease (MRD) detection and recurrence monitoring in patients previously diagnosed with cancer. Signatera’s tumor-informed assay is optimized to detect low levels of ctDNA, with high accuracy in identifying MRD and recurrence with longer lead times. Signatera has been clinically validated in multiple cancer types including colorectal, non-small cell lung, breast, and bladder cancers. Look deeper atnatera.com/oncology

26
Q

Oncopeptides

A

PEPAXTO

27
Q

OneOncology

A

For physicians by physicians. OneOncology positions independent community oncologists to drive the future of cancer care through a patient-centric, physician-driven, and technology-powered model at a time when community cancer care needs it most.

28
Q

Pharmacosmos

A

Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit us atwww.monoferric.comto learn more.

29
Q

Pharmacyclics

A

IMBRUVICA(R) (ibrutinib)

30
Q

Puma Biotech

A

Nerlynx (neratinib)

31
Q

Regeneron

A

Since 2007, Regeneron and Sanofi have collaborated to help people with debilitating and complex conditions that are often difficult to diagnose and treat, using fully-human monoclonal antibodies. Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. ONC.21.01.0033 3/21 © 2021 Regeneron Pharmaceuticals, Inc., and sanofi-aventis U.S. LLC. All rights reserved.

32
Q

Rxvantage

A

RxVantage is a free, web-based platform that over 1,000 oncology practices use to seamlessly access and engage the experts and resources they need from any pharma and biotech company, according to their preferences. The customizable tool offers practices a personalized digital directory of the specific MSLs, reimbursement specialists, nurse educators, KAMs, and product reps responsible for supporting your practice. Instant and mass messaging tools facilitate seamless communication and our scheduling solution streamlines all meeting logistics, in-person or digital, through intelligent automation and engagement rules that practices define. With no integrations or software to install, practices can launch their RxVantage account in less than 30 minutes to instantly improve the way they access information and expertise from pharma.

33
Q

Sanofi

A

SARCLISA
ELITEK
JEVTANA

34
Q

Seagen

A

ADCETRIS (brentuximab vedotin) for injection
TUKYSA (tucatinib) tablets
PADCEV (enfortumab vedotin-ejfv)

35
Q

Seattle Genetics

A

Seattle Genetics is a global biotechnology company that discovers, develops and commercializes transformative cancer-targeting therapies. ADCETRIS® (brentuximab vedotin) and PADCEVTM (enfortumab vedotin-ejfv) use the company’s industry-leading antibody-drug conjugate technology designed to bring a powerful medicine directly to cancer cells. ADCETRIS is approved for the treatment of several types of CD30-expressing lymphomas, and PADCEV is approved to treat adults with metastatic urothelial cancer.

36
Q

Sun Pharma

A

Sun Pharma is the 4th largest specialty generic pharmaceutical company in the world, providing high-quality, affordable medicines in over 150 countries. Our mission is to enhance people’s lives with innovative and quality generic, branded, and over-the-counter medicines, providing exceptional value in our communities. In the US, Sun Pharma is focused on helping patients in Generics, Dermatology, Oncology, Ophthalmology, and Long-Term Care.
Yonsarx

37
Q

Taiho Oncology

A

INQOVI

Lonsurf (trifluridine and tipiracil) tablets

38
Q

Takeda

A

Ninlaro
Alunbrig
Iclusig

Oncology (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions